[Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
Xia
Xiao-dong
XD
Dai
Yuan-rong
YR
Xu
Zheng-jie
ZJ
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000631:Aminopyridines / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D001549:Benzamides / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002264:Carboxylic Acids; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D003509:Cyclohexanecarboxylic Acids; D003521:Cyclopropanes; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D009570:Nitriles; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use
D000631:Aminopyridines; D001549:Benzamides; D001993:Bronchodilator Agents; D002264:Carboxylic Acids; D003509:Cyclohexanecarboxylic Acids; D003521:Cyclopropanes; D009570:Nitriles; D010726:Phosphodiesterase Inhibitors; D011725:Pyridines; C424423:Roflumilast; C433247:Cilomilast; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; C087566:piclamilast